To investigate the potential binding of PAUF with TLR4 on the plasma membrane of the cancer cells, we used a chemical crosslinker BS3, which is a membrane-impermeable agent that possesses a spacer arm of 1.14 nm. This evidence concerns the gene TLR4 and cancer.